Quince Therapeutics, Inc. (QNCX) Dividend History

Quince Therapeutics, Inc. (QNCX) is a biotechnology company focused on developing therapies for bone-related disorders. It aims to address unmet medical needs by advancing innovative treatments targeting bone regeneration and repair.

611 Gateway Blvd., Suite 273, South San Francisco, CA, 94080
Phone: 415-910-5717
Website:

Dividend History

Quince Therapeutics, Inc. currently does not pay dividends

Company News

  • Quince Therapeutics and XBiotech are included in this Analyst Blog.

    Zacks Investment Research
    Featured Companies: XBIT
  • Two microcap biotech stocks to consider for the science-challenged among us.

    Zacks Investment Research
    Featured Companies: IBBQ XBIT
  • The Dow Jones closed higher by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. SHF Holdings The Trade: SHF Holdings, Inc. (NASDAQ: SHFS) Chief Legal Officer Donald Emmi acquired a total of 66,000 shares an average price of $0.87. To acquire these shares, it cost around $57,420. The company’s CEO also bought 20,000 shares of the company. What’s Happening: On Nov. 14, SHF Hldgs posted a loss for ...

    Benzinga
    Featured Companies: SHFS SILO UPXI
  • The Dow Jones closed higher by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Vintage Wine Estates The Trade: Vintage Wine Estates, Inc. (NASDAQ: VWE) Director Timothy Proctor acquired a total of 31,852 shares an average price of $0.57. To acquire these shares, it cost around $18,155. What’s Happening: On Nov. 14, Vintage Wine Estates posted a wider-than-expected quarterly loss. What Vintage Wine Estates Does: Vintage Wine Estates Inc is a family of wineries and wines whose singular focus ...

    Benzinga
    Featured Companies: RDW
  • Gainers RVL Pharmaceuticals plc (NASDAQ: RVLP) shares rose 181.8% to $0.2201 in pre-market trading. Novo Integrated Sciences, Inc. (NASDAQ: NVOS) shares rose 86% to $0.3739 in pre-market trading. Novo Integrated Sciences and Blacksheep Trust signed a One Billion Dollar Master Collateral Transfer Agreement for the purpose and general use of monetization by Novo for a period of up to 15 years. Polished.com Inc. (NYSE: POL) shares surged 35% to $0.1060 in pre-market trading. Polished.com plans to hold a special meeting of stockholders to approve reverse stock split. OpGen, Inc. (NASDAQ: OPGN) shares gained 34.3% to $0.27 in pre-market trading. Brooge Energy Limited (NASDAQ: BROG) shares rose 23% to $6.64 in pre-market trading after gaining 7% on Thursday. iSun, Inc. (NASDAQ: ISUN) gained 18.3% to $0.2550 in pre-market trading. iSun recently filed for offering of up to 10.96 million shares of common stock by the selling stockholders. T2 Biosystems, Inc. (NASDAQ: TTOO) rose 17.2% to $0.2090 in pre-market trading. OPKO Health, Inc. (NASDAQ: OPK) shares ...

    Benzinga
    Featured Companies: BROG FEMY NKE OPK OST RSLS TNXP VRAR
Dividend data last updated 06/07/2025 09:18:04 UTC